TRUE Private Wealth Advisors’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-200
Closed -$2K 779
2020
Q3
$2K Hold
200
﹤0.01% 642
2020
Q2
$2K Hold
200
﹤0.01% 637
2020
Q1
$2K Buy
+200
New +$2K ﹤0.01% 624